Keith Heinzerling
Overview
Explore the profile of Keith Heinzerling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
498
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raison C, Sanacora G, Woolley J, Heinzerling K, Dunlop B, Brown R, et al.
JAMA
. 2023 Aug;
330(9):843-853.
PMID: 37651119
Importance: Psilocybin shows promise as a treatment for major depressive disorder (MDD). Objective: To evaluate the magnitude, timing, and durability of antidepressant effects and safety of a single dose of...
2.
Kelly D, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari R
Neurosurgery
. 2022 Dec;
92(4):680-694.
PMID: 36512813
After a decades-long pause, psychedelics are again being intensely investigated for treating a wide range of neuropsychiatric ailments including depression, anxiety, addiction, post-traumatic stress disorder, anorexia, and chronic pain syndromes....
3.
Young S, Lee S, Perez H, Gill N, Gelberg L, Heinzerling K
Heliyon
. 2020 Mar;
6(3):e03471.
PMID: 32181385
Interventions are urgently needed to reduce prescription opioid misuse risk factors, including anxiety and concomitant use of sedatives. However, only a limited number of randomized controlled opioid intervention trials have...
4.
Young S, Koussa M, Lee S, Perez H, Gill N, Gelberg L, et al.
J Addict Dis
. 2019 Jan;
37(1-2):96-101.
PMID: 30614403
Assess whether the Harnessing Online Peer Education (HOPE) social media-based support group can engage patients on opioids at risk for misuse/overdose to discuss risk reduction strategies. Fifty-one patients on chronic...
5.
Briones M, Shoptaw S, Cook R, Worley M, Swanson A, Moody D, et al.
Drug Alcohol Depend
. 2018 Jun;
189:30-36.
PMID: 29860057
Background: Previous studies have suggested that varenicline, an α4β2 nicotinic receptor partial agonist, and α7 nicotinic receptor full agonist, may be effective for the treatment of methamphetamine (MA) dependence due...
6.
Severino A, Shadfar A, Hakimian J, Crane O, Singh G, Heinzerling K, et al.
Front Psychiatry
. 2018 May;
9:119.
PMID: 29740351
Prescription opioid misuse is an ongoing and escalating epidemic. Although these pharmacological agents are highly effective analgesics prescribed for different types of pain, opioids also induce euphoria, leading to increasing...
7.
Young S, Heinzerling K
J Subst Use
. 2018 Mar;
22(6):592-596.
PMID: 29551953
Social media technologies are newly emerging tools that can be used to address the growing prescription drug epidemic. In this study, we sought to determine the feasibility and acceptability of...
8.
Watkins K, Ober A, Lamp K, Lind M, Diamant A, Chan Osilla K, et al.
Prog Community Health Partnersh
. 2018 Jan;
11(4):397-407.
PMID: 29332853
Background: Effective treatments for opioid and alcohol use disorders (OAUD) are available, yet only a small percentage of those needing treatment receive it. Objectives: This paper describes a collaborative planning...
9.
Ober A, Watkins K, Hunter S, Ewing B, Lamp K, Lind M, et al.
BMC Fam Pract
. 2017 Dec;
18(1):107.
PMID: 29268702
Background: Millions of people with substance use disorders (SUDs) need, but do not receive, treatment. Delivering SUD treatment in primary care settings could increase access to treatment because most people...
10.
Watkins K, Ober A, Lamp K, Lind M, Setodji C, Chan Osilla K, et al.
JAMA Intern Med
. 2017 Aug;
177(10):1480-1488.
PMID: 28846769
Importance: Primary care offers an important and underutilized setting to deliver treatment for opioid and/or alcohol use disorders (OAUD). Collaborative care (CC) is effective but has not been tested for...